Immunology
173.7K views | +16 today
Follow
Immunology
Teaching and Learning Immunology. Information you never would have searched for!
Your new post is loading...
Your new post is loading...
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review and Collection
Scoop.it!

The Journey from Discoveries in Fundamental Immunology to Cancer Immunotherapy: Cancer Cell

The Journey from Discoveries in Fundamental Immunology to Cancer Immunotherapy: Cancer Cell | Immunology | Scoop.it

Recent advances in cancer immunotherapy have directly built on 50 years of fundamental and technological advances that made checkpoint blockade and T cell engineering possible. In this review, we intend to show that research, not specifically designed to bring relief or cure to any particular disease, can, when creatively exploited, lead to spectacular results in the management of cancer. The discovery of thymus immune function, T cells, and immune surveillance bore the seeds for today’s targeted immune interventions and chimeric antigen receptors.


Via Krishan Maggon
Gilbert C FAURE's insight:
Perspective

The spectacular successes that have been achieved in the immune management of various clinical conditions and especially cancer were borne out of basic research that was creatively exploited by translational researchers. No one could have predicted that investigating how or why virus-induced lymphocytic leukemia needs to develop in the neonatal mouse thymus would reveal the latter’s immunological function. The extensive worldwide research that followed was crucial to our understanding of what cells and molecules regulate T cell activation and how this may be used to our benefit in the clinic.

Krishan Maggon 's curator insight, April 14, 2015 12:11 AM

Cancer Cell

 

Volume 27, Issue 4, p439–449, 13 April 2015

 

The Journey from Discoveries in Fundamental Immunology to Cancer ImmunotherapyJacques F.A.P. Miller, Michel Sadelain DOI: http://dx.doi.org/10.1016/j.ccell.2015.03.007

  

 

 

Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review and Collection
Scoop.it!

AJMC Panel Explores Immuno-oncology, and What Making Cancer a Chronic a Chronic Condition Means for Payers.

AJMC Panel Explores Immuno-oncology, and What Making Cancer a Chronic  a Chronic Condition Means for Payers. | Immunology | Scoop.it
AJMC Panel Explores Immuno-oncology, and What Making Cancer a Chronic ...

Via Krishan Maggon
Gilbert C FAURE's insight:

The emergence of immuno-oncology, in which a patient’s own immune system is activated to fight the cancer, has shown promise in certain tumor subtypes, notably with therapies such as ipilimumab, which has been approved for metastatic melanoma.

But immuno-oncology presents certain challenges. Patients may not be “cured” in the conventional sense; rather, the disease may be converted to a chronic condition. In some cases the person can return to work, but in others, that’s not possible. This raises important policy choices when employers pay for healthcare. - See more at: http://www.ajmc.com/publications/evidence-based-oncology/2014/November-2014/AJMC-Panel-Explores-Immuno-oncology-and-What-Making-Cancer-a-Chronic-Condition-Means-for-Payers#sthash.Cr9sqCWa.dpuf

No comment yet.